Same Route of Administration: For example, a drug approved for oral administration and a compounded version intended for oral administration
Weight loss of any cause including GLP-1-induced weight loss can reduce bone density
Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y et al (2019) DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
The researchers noted that semaglutide was also the most commonly prescribed GLP-1 medication during the study period, which may have provided greater statistical power to detect differences among medications
Semaglutide is a lab-made copy of a gut hormone that targets a single receptor to reduce appetite, slow digestion, and help regulate blood sugar